THE PROGNOSTIC IMPACT OF CYTOGENETIC AND GENETIC ABNORMALITY FOR THE ACHIEVEMENT OF THE SECOND COMPLETE REMISSION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

被引:0
|
作者
Fukunaga, K. [1 ]
Yamaguchi, H. [1 ]
Wakita, S. [1 ]
Omori, I. [1 ]
Yui, S. [1 ]
Ryotokuji, T. [1 ]
Hirakawa, T. [1 ]
Arai, K. [1 ]
Kitano, T. [1 ]
Kosaka, F. [1 ]
Dan, K. [2 ]
Inokuchi, K. [1 ]
机构
[1] Nippon Med Sch, Dept Internal Med, Div Hematol, Tokyo 113, Japan
[2] Ryotokuji Univ, Med Educ Ctr, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P819
引用
收藏
页码:300 / 300
页数:1
相关论文
共 50 条
  • [1] Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    O'Brien, Susan M.
    Faderl, Stefan
    Burger, Jan A.
    Garris, Rebecca
    Qiao, Wei
    Huang, Xuelin
    Jain, Nitin
    Konopleva, Marina
    Kadia, Tapan M.
    Daver, Naval
    Borthakur, Gautam
    Cortes, Jorge E.
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (04) : 385 - 389
  • [2] Independent Prognostic Impact of CD15 for Achievement of Complete Remission in Patients with Acute Myeloid Leukemia
    Ceglie, Teresa
    Chisini, Marta
    Vozella, Federico
    Colafigli, Gioia
    Stefanizzi, Caterina
    Salaroli, Adriano
    D'Angio, Mariella
    Mancini, Marco
    Diverio, Daniela
    Breccia, Massimo
    Mancini, Francesca
    Raponi, Sara
    Minotti, Clara
    Trisolini, Silvia
    Capria, Saveria
    Testi, Anna Maria
    Guarini, Anna
    Latagliata, Roberto
    De Propris, Maria Stefania
    Foa, Robin
    BLOOD, 2014, 124 (21)
  • [3] Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia
    Chisini, Marta
    Stefanizzi, Caterina
    Ceglie, Teresa
    Raponi, Sara
    Vozella, Federico
    Colafigli, Gioia
    Salaroli, Adriano
    D'Angio, Mariella
    Mancini, Marco
    Diverio, Daniela
    Breccia, Massimo
    Mancini, Francesca
    Minotti, Clara
    Trisolini, Silvia
    Capria, Saveria
    Testi, Anna Maria
    Guarini, Anna
    Latagliata, Roberto
    de Propris, Maria Stefania
    Foa, Robin
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 804 - 809
  • [4] Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia
    Lee, S
    Tallman, MS
    Oken, MM
    Cassileth, PA
    Bennett, JM
    Wiernik, PH
    Rowe, JM
    LEUKEMIA, 2000, 14 (08) : 1345 - 1348
  • [5] Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia
    S Lee
    MS Tallman
    MM Oken
    PA Cassileth
    JM Bennett
    PH Wiernik
    JM Rowe
    Leukemia, 2000, 14 : 1345 - 1348
  • [6] Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission
    Shimizu, Hiroaki
    Mukae, Junichi
    Shingai, Naoki
    Toya, Takashi
    Najima, Yuho
    Kobayashi, Takeshi
    Hatsumi, Nahoko
    Takada, Satoru
    Handa, Hiroshi
    Haraguchi, Kyoko
    Okuyama, Yoshiki
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    Doki, Noriko
    BLOOD, 2021, 138
  • [7] Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia.
    Tallman, MS
    Lee, S
    Oken, MM
    Cassileth, PA
    Bennett, JM
    Wiernik, PH
    Rowe, JM
    BLOOD, 1999, 94 (10) : 224B - 224B
  • [8] PROGNOSTIC VALUE OF HEMATOGONES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION
    Hassanein, M.
    Haggag, R.
    El Shorbagy, S. M.
    Ebian, H. F.
    HAEMATOLOGICA, 2015, 100 : 651 - 651
  • [9] Optimal Therapy for Adult Patients with Acute Myeloid Leukemia in First Complete Remission
    Wiernik, Peter H.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (02) : 171 - 186
  • [10] Optimal Therapy for Adult Patients with Acute Myeloid Leukemia in First Complete Remission
    Peter H. Wiernik
    Current Treatment Options in Oncology, 2014, 15 : 171 - 186